Culturally adaptive storytelling method to improve hypertension control in Vietnam - "We talk about our hypertension": study protocol for a feasibility cluster-randomized controlled trial

Jeroan J Allison, Hoa L Nguyen, Duc A Ha, Germán Chiriboga, Ha N Ly, Hanh T Tran, Ngoc T Phan, Nguyen C Vu, Minjin Kim, Robert J Goldberg, Jeroan J Allison, Hoa L Nguyen, Duc A Ha, Germán Chiriboga, Ha N Ly, Hanh T Tran, Ngoc T Phan, Nguyen C Vu, Minjin Kim, Robert J Goldberg

Abstract

Background: Vietnam is experiencing an epidemiologic transition with an increased prevalence of non-communicable diseases. At present, the major risk factors for cardiovascular disease (CVD) are either on the rise or at alarming levels in Vietnam; inasmuch, the burden of CVD will continue to increase in this country unless effective prevention and control measures are put in place. A national survey in 2008 found that the prevalence of hypertension (HTN) was approximately 25 % among Vietnamese adults and it increased with advancing age. Therefore, novel, large-scale, and sustainable interventions for public health education to promote engagement in the process of detecting and treating HTN in Vietnam are urgently needed.

Methods: A feasibility randomized trial will be conducted in Hung Yen province, Vietnam to evaluate the feasibility and acceptability of a novel community-based intervention using the "storytelling" method to enhance the control of HTN in adults residing in four rural communities. The intervention will center on stories about living with HTN, with patients speaking in their own words. The stories will be obtained from particularly eloquent patients, or "video stars," identified during Story Development Groups. The study will involve two phases: (i) developing a HTN intervention using the storytelling method, which is designed to empower patients to facilitate changes in their lifestyle practices, and (ii) conducting a feasibility cluster-randomized trial to investigate the feasibility, acceptability, and potential efficacy of the intervention compared with usual care in HTN control among rural residents. The trial will be conducted at four communes, and within each commune, 25 individuals 50 years or older with HTN will be enrolled in the trial resulting in a total sample size of 100 patients.

Discussion: This feasibility trial will provide the necessary groundwork for a subsequent large-scale, fully powered, cluster-randomized controlled trial to test the efficacy of our novel community-based intervention. Results from the full-scale trial will provide health policy makers with practical evidence on how to combat a key risk factor for CVD using a feasible, sustainable, and cost-effective intervention that could be used as a national program for controlling HTN in Vietnam and other developing countries.

Trial registration: ClinicalTrials.gov.

Registration number: https://ichgcp.net/clinical-trials-registry/NCT02483780 (registration date June 22, 2015).

Figures

Fig. 1
Fig. 1
Adapted Slater Model of Narrative Communication

References

    1. Health Statistics Year Book 2006. Hanoi, Vietnam: Ministry of Health; 2007.
    1. Health Statistics Yearbook 2000. Hanoi, Vietnam: Ministry of Health; 2001.
    1. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al. Disease control priorities in developing countries. 2. Washington DC: World Bank Publications; 2006.
    1. Hoang VM, Dao LH, Wall S, Nguyen TK, Byass P. Cardiovascular disease mortality and its association with socioeconomic status: findings from a population-based cohort study in rural Vietnam, 1999–2003. Prev Chronic Dis. 2006;3:A89.
    1. Vos T. A personal communication regarding to unpublished Burden of Disease study results of Developing Evidence Base for Health Policy in Vietnam (VINE) project. 2009.
    1. Son PT, Quang NN, Viet NL, Khai PG, Wall S, Weinehall L, et al. Prevalence, awareness, treatment and control of hypertension in Vietnam-results from a national survey. J Hum Hypertens. 2012;26:268–80. doi: 10.1038/jhh.2011.18.
    1. Khai GP, Viet LN, Son TP, Quang NN, Yen BTN, Hung QN. Epidemiology survey of hypertension and its risk factors in Vietnam. Hanoi, Vietnam: presentation at World Health Organization’s office; 2008.
    1. Risks R. Promoting healthy life. Geneva: World Health Organization; 2002.
    1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206–52. doi: 10.1161/01.HYP.0000107251.49515.c2.
    1. Hoang VM, Byass P, Wall S. Mortality from cardiovascular diseases in Bavi District, Vietnam. Scand J Public Health. 2003;31:26–31. doi: 10.1080/14034950310015077.
    1. Ha DA, Goldberg RJ, Allison JJ, Chu TH, Nguyen HL. Prevalence, awareness, treatment, and control of high blood pressure: a population-based survey in Thai Nguyen, Vietnam. PLoS One. 2013;8 doi: 10.1371/journal.pone.0066792.
    1. Tuan NT, Tuong PD, Popkin BM. Body mass index (BMI) dynamics in Vietnam. Eur J Clin Nutr. 2008;62:78–86. doi: 10.1038/sj.ejcn.1602675.
    1. Houston TK, Allison JJ, Sussman M, Horn W, Holt CL, Trobaugh J, et al. Culturally appropriate storytelling to improve blood pressure. Ann Intern Med. 2011;154:77–84. doi: 10.7326/0003-4819-154-2-201101180-00004.
    1. Saha S, Beach MC, Cooper LA. Patient centeredness, cultural competence and healthcare quality. J Natl Med Assoc. 2008;100:1275–85. doi: 10.1016/S0027-9684(15)31505-4.
    1. Rosenstock IM. The health belief model and preventive health behavior. Health Educ Behav. 1974;2:354–86. doi: 10.1177/109019817400200405.
    1. Slater MD, Rouner D. Entertainment—education and elaboration likelihood: understanding the processing of narrative persuasion. Commun Theory. 2002;12:173–91.
    1. Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens. 2008;10:644–6. doi: 10.1111/j.1751-7176.2008.08329.x.
    1. Borzecki AM, Oliveria SA, Berlowitz DR. Barriers to hypertension control. Am Heart J. 2005;149:785–94. doi: 10.1016/j.ahj.2005.01.047.
    1. Hill MN, Sutton BS. Barriers to hypertension care and control. Curr Hypertens Rep. 2000;2:445–50. doi: 10.1007/s11906-000-0026-y.
    1. Green MC. Transportation into narrative worlds: The role of prior knowledge and perceived realism. Discourse Processes. 2004;38:247–66. doi: 10.1207/s15326950dp3802_5.
    1. Green MC, Brock TC. The role of transportation in the persuasiveness of public narratives. J Pers Soc Psychol. 2000;79:701–21. doi: 10.1037/0022-3514.79.5.701.
    1. National survey on utilization of phone, Internet and television. Hanoi, Vietnam: Ministry of Information and Communications. 2011.
    1. Nielsen J, Mack R. Usability inspection methods. New York: Wiley; 1994.
    1. Kushniruk AW, Patel VL, Cimino JJ. Usability testing in medical informatics: cognitive approaches to evaluation of information systems and user interfaces. Proc AMIA Annu Fall Symp. 1997:218–22.
    1. Kushniruk AW, Patel VL. Cognitive computer-based video analysis: its application in assessing the usability of medical systems. Medinfo. 1995;8:1566–9.
    1. Pan Y, de la Puente M. Census Bureau guideline for the translation of data collection instruments and supporting materials: documentation on how the guideline was developed. 2005. .Accessed 24 Aug 2005.
    1. Census Bureau’s Methodology and Standards Council. Pretesting questionnaires and related materials for surveys and censuses. 2003. .Accessed 25 Jul 2003.
    1. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74. doi: 10.1097/00005650-198601000-00007.
    1. Minh HV, Byass P, Chuc NT, Wall S. Gender differences in prevalence and socioeconomic determinants of hypertension: findings from the WHO STEPs survey in a rural community of Vietnam. J Hum Hypertens. 2006;20:109–15. doi: 10.1038/sj.jhh.1001942.
    1. Pham LH, Au TB, Blizzard L, Truong NB, Schmidt MD, Granger RH, et al. Prevalence of risk factors for non-communicable diseases in the Mekong Delta, Vietnam: results from a STEPS survey. BMC Public Health. 2009;9:291. doi: 10.1186/1471-2458-9-291.
    1. Ng N, Van Minh H, Tesfaye F, Bonita R, Byass P, Stenlund H, et al. Combining risk factors and demographic surveillance: potentials of WHO STEPS and INDEPTH methodologies for assessing epidemiological transition. Scand J Public Health. 2006;34:199–208. doi: 10.1080/14034940500204506.
    1. Hoang VM, Byass P, Dao LH, Nguyen TK, Wall S. Risk factors for chronic disease among rural Vietnamese adults and the association of these factors with sociodemographic variables: findings from the WHO STEPS survey in rural Vietnam, 2005. Prev Chronic Dis. 2007;4:A22.
    1. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663–94. doi: 10.7326/0003-4819-134-8-200104170-00012.
    1. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Br Med J. 2010;340:c869. doi: 10.1136/bmj.c869.
    1. Eysenbach G. CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res. 2011;13 doi: 10.2196/jmir.1923.
    1. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277–88. doi: 10.1177/1049732305276687.
    1. Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol. 2004;57:785–94. doi: 10.1016/j.jclinepi.2003.12.013.
    1. Campbell MK, Fayers PM, Grimshaw JM. Determinants of the intracluster correlation coefficient in cluster randomized trials: the case of implementation research. Clinical Trials. 2005;2:99–107. doi: 10.1191/1740774505cn071oa.
    1. Murray DM, Pals SL, Blitstein JL, Alfano CM, Lehman J. Design and analysis of group-randomized trials in cancer: a review of current practices. J Natl Cancer Inst. 2008;100:483–91. doi: 10.1093/jnci/djn066.
    1. Murray DM, Varnell SP, Blitstein JL. Design and analysis of group-randomized trials: a review of recent methodological developments. Am J Public Health. 2004;94:423–32. doi: 10.2105/AJPH.94.3.423.
    1. Leon AC, Davis LL, Kraemer HC. The role and interpretation of pilot studies in clinical research. J Psychiatr Res. 2011;45:626–9. doi: 10.1016/j.jpsychires.2010.10.008.
    1. Kraemer HC, Mintz J, Noda A, Tinklenberg J, Yesavage JA. Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry. 2006;63:484–9. doi: 10.1001/archpsyc.63.5.484.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj